You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

20 Items

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Document Status: Current
ID: 2-29
Version: 4

Feb 2024

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Mar 2024

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Nov 2024

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Document Status: Current
ID: GL END 7-24

Nov 2024

Comparison of PET/CT and PET/MR Imaging in Oncology

Document Status: Current
ID: ES PET 16
Version: 2

Apr 2024

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Jan 2024

Endometrial Cancer Molecular Testing Recommendations Report

Document Status: Current
Version: 1

Nov 2024

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Document Status: Current
Version: PET 2023-2

Jun 2024

Exercise for People with Cancer

Document Status: Current
ID: 19-5
Version: 2

Jul 2024

Fear of Cancer Recurrence Guideline

Document Status: Current
ID: GL 19-7

Mar 2024

First-line treatment of advanced-stage Hodgkin lymphoma

Document Status: Current
ID: ES 6-25

Oct 2024

Follow-up and Surveillance of Curatively Treated Lung Cancer Patients

Document Status: Current
ID: 26-3
Version: 2

Feb 2024